Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2014
09/23/2014US8841262 Agent for inhibiting peritoneal membrane thickening
09/23/2014US8841261 Functional powdery product
09/23/2014US8841100 Use of methylsulfonylmethane (MSM) to modulate microbial activity
09/23/2014US8840951 Method for preparation of a controlled release system
09/23/2014US8840935 Orally administrable films and preparation thereof
09/23/2014US8840933 Method of treating neuronal injury by administering magnesium chloride and PEG
09/23/2014US8840931 Pharmaceutical compositions for dehydrating, atrophying and eliminating pathological tissues
09/23/2014US8840930 Pharmaceutical composition for inhalation
09/23/2014US8840929 Cosmetic compositions with near infra-red (NIR) light-emitting material and methods therefor
09/23/2014US8840928 Tamper-resistant pharmaceutical compositions of opioids and other drugs
09/23/2014US8840925 Orally disintegrating tablet compositions of lamotrigine
09/23/2014US8840924 Compositions and methods of making rapidly dissolving ionically masked formulations
09/23/2014US8840923 Slow-release pharmaceutical formulation and process for its preparation
09/23/2014US8840922 Transdermally absorbable donepezil-containing preparation
09/23/2014US8840921 Patch production technology
09/23/2014US8840920 Composite structure including a low vinyl acetate layer
09/23/2014US8840919 Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
09/23/2014US8840915 Pharmaceutical compositions for sustained release delivery of peptides
09/23/2014US8840913 Malleable multi-component implants and materials therefor
09/23/2014US8840911 Moisturizing hand sanitizer
09/23/2014US8840884 Antibody-containing solution pharmaceuticals
09/23/2014US8840872 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
09/23/2014US8840869 Body cavity foams
09/23/2014US8840602 Systems and methods for anesthetizing ear tissue
09/23/2014CA2774264C Improved device and method for delivery of a medicament
09/23/2014CA2756811C Liposome composition of eribulin or its pharmacologically permissible salt
09/23/2014CA2748860C Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
09/23/2014CA2718697C Extended release formulation containing a wax
09/23/2014CA2715133C Fine powder of polyamide from renewable materials and method for making such powder
09/23/2014CA2653786C Oral preparation comprising pioglitazone
09/23/2014CA2648537C Method for preparing 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-11.beta.-yl]benzaldehyde (e)-oxime (asoprisnil)
09/23/2014CA2648460C Calcium phosphate complex and salts in oral delivery systems
09/23/2014CA2616515C Antihistamine- and corticosteroid- containing liposome composition and its use for the manufacture of a medicament for treating rhinitis and related disorders
09/23/2014CA2613558C Manufacturing apparatus of transdermal absorption preparation
09/23/2014CA2611114C An entacapone-containing oral dosage form
09/23/2014CA2610767C Tanaproget compositions containing ethinyl estradiol
09/23/2014CA2609612C Use of huperzine to treat epilepsy
09/23/2014CA2599831C Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter
09/23/2014CA2589632C Injectable non-aqueous suspension
09/18/2014WO2014146130A2 Exercise machine
09/18/2014WO2014146125A1 Management of tractional membranes
09/18/2014WO2014146077A1 Multi-stage biodegradable drug delivery platform
09/18/2014WO2014146044A1 Administration of nicotinamide mononucleotide in the treatment of disease
09/18/2014WO2014145839A2 Liposomal vaccine adjuvants and methods of processing or using same
09/18/2014WO2014145749A1 Targeted polymeric inflammation-resolving nanoparticles
09/18/2014WO2014145710A1 Parenteral diclofenac composition
09/18/2014WO2014145701A2 Automatically deployable communications system
09/18/2014WO2014145699A1 System and method for fabrication of uniform polymer films containing nano and micro particles via continuous drying process
09/18/2014WO2014145638A1 Drug delivery devices with drug-permeable component and methods
09/18/2014WO2014145606A1 Multimodal silica-based nanoparticles
09/18/2014WO2014145573A1 Coated magnetic nanoparticles for imaging enhancement and drug delivery
09/18/2014WO2014145540A2 Systems and methods for providing alignment in total knee arthroplasty
09/18/2014WO2014145509A1 Enteric ct contrast material based on low-z atoms
09/18/2014WO2014145310A2 Systems and methods for gamified audience interaction platform
09/18/2014WO2014145303A1 Intravenous emulsions of triptolide as immunomodulators and anticancer agents i
09/18/2014WO2014145302A2 Synthesis of ent-progesterone and intermediates thereof
09/18/2014WO2014145242A1 Peptide-coated polymer carriers
09/18/2014WO2014145219A1 Orally administrable compositions comprising calcium
09/18/2014WO2014145195A1 Pharmaceuticals comprising a ph-dependent component and ph-raising agent
09/18/2014WO2014145187A1 Controlled drug release liposome composition
09/18/2014WO2014145093A1 Fine dry particulate resveratrol active agent compositions and topical formulations including the same
09/18/2014WO2014145037A1 Methods and compositions for enhancing oxygen levels in tissues
09/18/2014WO2014145034A1 Fine dry particulate retinoid active agent compositions and topical formulations including the same
09/18/2014WO2014144973A1 Microarray for delivery of therapeutic agent, methods of use, and methods of making
09/18/2014WO2014144895A1 Microcrystalline diketopiperazine compositions and methods
09/18/2014WO2014144894A1 Methods and systems for conditioning of particulate crystalline materials
09/18/2014WO2014144888A1 Calcium sulfate-resin hybrid materials and methods of using and making the same
09/18/2014WO2014144712A1 Topical formulations and methods for drug delivery
09/18/2014WO2014144661A1 Rapidly dispersible dosage form of topiramate
09/18/2014WO2014144425A1 Managing osteoporosis with hmw peg
09/18/2014WO2014144421A1 Ceramide reversal of multi-drug resistance
09/18/2014WO2014144407A1 Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof
09/18/2014WO2014144366A1 Steroid hormone delivery systems and methods of preparing the same
09/18/2014WO2014144365A1 Nano-liposomal formulations and methods of use
09/18/2014WO2014144348A2 Using entity repository to enhance advertisement display
09/18/2014WO2014144309A1 Sustained release microspheres and method of producing the same
09/18/2014WO2014144241A1 Sublingual and buccal film compositions
09/18/2014WO2014144178A1 Reduction in stress cracking of films
09/18/2014WO2014144066A1 Drug delivery devices and methods for drug delivery
09/18/2014WO2014143990A1 Preparations derived from placental materials of making and using same
09/18/2014WO2014143943A1 Preparations containing hepatocyte growth factor and hyaluronic acid, and methods of making and using same
09/18/2014WO2014143941A1 Stabilized modified release vitamin d formulation and method of administring same
09/18/2014WO2014143883A1 Low-glycerin formulations for hiv treatment and prevention
09/18/2014WO2014143839A1 High drug load buprenorphine microspheres and method of producing the same
09/18/2014WO2014143833A1 Fibers comprising poorly soluble drugs and/or proteins
09/18/2014WO2014143808A1 Hollow particles encapsulating a biological gas and methods of use
09/18/2014WO2014143806A1 Acid stable liposomal compositions
09/18/2014WO2014143646A1 Pharmaceutical composition of s-ketamine hydrochloride
09/18/2014WO2014143635A1 Compositions of a polyorthoester and an aprotic solvent
09/18/2014WO2014143629A1 Bimatoprost for enhancement of leptin production
09/18/2014WO2014143592A1 Inhibition of neovascularization by inhibition of prostanoid ip receptors
09/18/2014WO2014143591A1 Inhibition of neovascularization by simultaneous inhibition of prostanoid ip and ep4 receptors
09/18/2014WO2014143536A1 Extended release compositions comprising hydrocodone and acetaminophen for rapid onset and prolonged analgesia that may be administered without regard to food
09/18/2014WO2014143453A1 Phosphodiesterase inhibitor treatment
09/18/2014WO2014143380A1 Extended-release topiramate capsules
09/18/2014WO2014143156A1 Doxycycline formulations, and methods of treating rosacea
09/18/2014WO2014143146A1 Methods of administering monomethyl fumarate
09/18/2014WO2014143127A1 Emulsion formulations
09/18/2014WO2014143085A1 Pharmaceutical formulation containing glycosaminoglycan
09/18/2014WO2014143031A1 Compositions and methods including celecoxib and plumbagin relating to treatment of cancer
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 2991